TheProfitWatch

RGNX - REGENXBIO Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
11.47 0.58 (5.06%) --- --- --- 0.3 (2.62%) 0.95 (8.38%) -0.01 (-0.08%) -0.01 (-0.08%)

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-1.38
Diluted EPS:
-1.38
Basic P/E:
-8.7319
Diluted P/E:
-8.7319
RSI(14) 1m:
0.0
VWAP:
12.05
RVol:
0.7957

Events

Period Kind Movement Occurred At
1m Price decrease 1m 11.84 -0.15 (-1.25%) Oct 15 13:32
1m Price increase 1m 11.48 +0.14 (+1.23%) Oct 15 09:30

Related News